Metraipolis › archive › dc_b1bdfffe6ee6
Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy — Europe PMC PMID:41353554
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41353554
- DOI
- 10.1186/s40780-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:19:16.760Z
- SHA-256 of the archived text
9a077cccaf728d7326c4b2939665d4b2b4cecec98f4a8fc131e80f3c75a835ba- Stable URL of this page
https://metraipolis.com/documento/dc_b1bdfffe6ee6
How to cite
Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy — Europe PMC PMID:41353554 — Europe PMC (en), https://europepmc.org/article/MED/41353554 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b1bdfffe6ee6 (Metraipolis archive dc_b1bdfffe6ee6, sha256 9a077cccaf728d7326c4b2939665d4b2b4cecec98f4a8fc131e80f3c75a835ba)
BibTeX
@misc{dcb1bdfffe6ee6,
title = {Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy — Europe PMC PMID:41353554},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41353554},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b1bdfffe6ee6; sha256 9a077cccaf728d7326c4b2939665d4b2b4cecec98f4a8fc131e80f3c75a835ba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41353554. Agents can read the archived copy with the MCP tool read_document.